Enovis (FRA:C520) Cyclically Adjusted FCF per Share: €1.89 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:C520 Enovis Corp FRA:C520
64 GF Score
Price €21.40
GF Value €41.96
! 6 Warning Signs
View Full Analysis

What is Enovis Cyclically Adjusted FCF per Share?

Enovis FRA:C520 -6.14% 64 Cyclically Adjusted FCF per Share is €1.89 as of Mar. 2026. GuruFocus rates FRA:C520 with a GF Score™ of 64/100 and a GF Value™ of €41.96. The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Enovis's adjusted free cash flow per share for the three months ended in Mar. 2026 was €-0.435. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is €1.89 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Enovis's average Cyclically Adjusted FCF Growth Rate was -22.70% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was -21.60% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was -13.90% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was -1.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Enovis was 12.50% per year. The lowest was -21.60% per year. And the median was 2.20% per year.

As of today (2026-07-16), Enovis's current stock price is €21.40. Enovis's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was €1.89. Enovis's Cyclically Adjusted Price-to-FCF of today is 11.32.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Enovis was 21.31. The lowest was 6.25. And the median was 12.60.


Enovis  (FRA:C520) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Enovis's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=21.40/1.89
=11.32

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Enovis was 21.31. The lowest was 6.25. And the median was 12.60.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Enovis Cyclically Adjusted FCF per Share Related Terms


Enovis Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Enovis's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enovis Cyclically Adjusted FCF per Share Chart

Enovis Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.57 4.48 3.51 2.87 1.96

Enovis Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.67 2.38 2.21 1.96 1.89

FRA:C520 vs INSP, PRCT, AHCO: Cyclically Adjusted FCF per Share Comparison

For the Medical Devices subindustry, Enovis's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Enovis Cyclically Adjusted Price-to-FCF vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Enovis's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Enovis's Cyclically Adjusted Price-to-FCF falls into.


FRA:C520
64GF Score
Enovis Corp FRA:C520
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Enovis Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Enovis's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.435/330.2130*330.2130
=-0.435

Current CPI (Mar. 2026) = 330.2130.

Enovis Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 0.668 241.018 0.915
201609 0.636 241.428 0.870
201612 2.847 241.432 3.894
201703 0.650 243.801 0.880
201706 0.929 244.955 1.252
201709 0.124 246.819 0.166
201712 1.472 246.524 1.972
201803 -0.270 249.554 -0.357
201806 0.472 251.989 0.619
201809 1.122 252.439 1.468
201812 2.153 251.233 2.830
201903 -1.919 254.202 -2.493
201906 0.836 256.143 1.078
201909 0.375 256.759 0.482
201912 0.773 256.974 0.993
202003 0.482 258.115 0.617
202006 0.344 257.797 0.441
202009 0.899 260.280 1.141
202012 1.722 260.474 2.183
202103 1.064 264.877 1.326
202106 0.943 271.696 1.146
202109 1.093 274.310 1.316
202112 1.080 278.802 1.279
202203 -0.649 287.504 -0.745
202206 -0.843 296.311 -0.939
202209 -0.027 296.808 -0.030
202212 -1.267 296.797 -1.410
202303 -0.395 301.836 -0.432
202306 -0.147 305.109 -0.159
202309 0.068 307.789 0.073
202312 0.680 306.746 0.732
202403 -1.230 312.332 -1.300
202406 -0.536 314.175 -0.563
202409 0.038 315.301 0.040
202412 0.600 315.605 0.628
202503 -0.731 319.799 -0.755
202506 0.052 322.561 0.053
202509 0.433 324.800 0.440
202512 0.482 324.054 0.491
202603 -0.435 330.213 -0.435

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of €1.89 mean?
Enovis (FRA:C520) has a Cyclically Adjusted FCF per Share of €1.89 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Enovis and its competitors.
Is Enovis' Cyclically Adjusted FCF per Share too high?
Enovis' current Cyclically Adjusted FCF per Share is €1.89. Overall, Enovis has a GF Score™ of 64/100, reflecting its overall financial health beyond just this single metric.
How does Enovis' Cyclically Adjusted FCF per Share compare to INSP and PRCT?
Enovis' Cyclically Adjusted FCF per Share of €1.89 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted FCF per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Enovis and its competitors. Enovis's current Cyclically Adjusted FCF per Share is €1.89. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Enovis stock overvalued right now?
Enovis (FRA:C520) has a current Cyclically Adjusted FCF per Share of €1.89. The stock's GF Value™ is €41.96, compared to a current price of €21.40 — trading 49% below its estimated fair value. The current Cyclically Adjusted FCF per Share is €1.89. Enovis' overall GF Score™ is 64/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Enovis (FRA:C520), the current Cyclically Adjusted FCF per Share is €1.89 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Enovis (FRA:C520) Overvalued in 2026?

Based on GuruFocus' analysis, Enovis stock appears to be undervalued. The current stock price of €21.40 is trading 49% below its estimated GF Value™ of €41.96.

Key valuation signals for FRA:C520:

  • Cyclically Adjusted FCF per Share: €1.89
  • GF Value™: €41.96 vs. price of €21.40 (49% below fair value)
  • GF Score™: 64/100 with 6 warning signs

No single metric tells the full story. See the FRA:C520 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Enovis Business Description

Address 2711 Centerville Road, Suite 400, Wilmington, DE, USA, 19808
Enovis Corp is a medical technology manufacturer and distributor of medical devices used in reconstructive surgery, rehabilitation, pain management, and physical therapy. Its products support patient care from injury prevention through post-surgical or post-injury rehabilitation and treatment of degenerative conditions. The company's reportable segments include Prevention & Recovery and Reconstructive segments. The majority of revenueis derived from the Prevention & Recovery segment, which includes products that are used by orthopedic specialists, primary care physicians, physical therapists, chiropractors, athletic trainers and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformitiesand sports-related injuries.
64GF Score

Get the complete analysis for FRA:C520

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€21.40
Price
€41.96
GF Value